Who
John M. Hamm
VP Chief Financial Officer
Company insider
Files Form 4 as: VP Chief Financial Officer, Cumberland Pharmaceuticals.
In numbers
- Trades disclosed
- 11
- Buys
- 1
- Sells
- 0
- Bought
- $8,930
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 23 Nov 2021
- Last trade
- 18 Mar 2026
- Last filed
- 20 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $8,4003,000 at $2.80 | filing |
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $8,4003,000 at $2.80 | filing |
| 17 Mar 2025filed 18 Mar 2025 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $14K2,750 at $5.17 | filing |
| 16 Mar 2025filed 18 Mar 2025 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $32K5,930 at $5.46 | filing |
| 25 Mar 2024filed 26 Mar 2024 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $9,4055,500 at $1.71 | filing |
| 23 Mar 2024filed 26 Mar 2024 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $805445 at $1.81 | filing |
| 27 Nov 2023filed 6 Dec 2023 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $588352 at $1.67 | filing |
| 24 Mar 2023filed 27 Mar 2023 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 16 Mar 2022filed 29 Apr 2022 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 16 Mar 2022filed 29 Apr 2022 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $52K20,000 at $2.59 | filing |
| 23 Nov 2021filed 3 Dec 2021 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $8,9303,800 at $2.35 | filing |
News
Head to Head Review: Cumberland Pharmaceuticals (NASDAQ:CPIX) & Eloxx Pharmaceuticals (NASDAQ:ELOX)CPIX · dailypolitical.com · 17 Oct 2026Contrasting Lifecore Biomedical (NASDAQ:LFCR) & Cumberland Pharmaceuticals (NASDAQ:CPIX)CPIX · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name John M. Hamm; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.